Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model
- 16 January 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 160 (2) , 284-296
Abstract
Background Interleukin (IL)‐20 is a recently discovered cytokine displaying increased levels in psoriatic lesions. Interestingly, IL‐20 levels decrease with antipsoriatic treatment, correlating with clinical improvement. However, the role of IL‐20 in the aetiology of psoriasis is unknown. Objectives In this study, we investigate the effects both of blocking IL‐20 signalling in psoriatic plaques and of adding IL‐20 to nonlesional psoriasis skin. Methods We employed the human skin xenograft transplantation model in which psoriatic plaques and nonlesional keratome skin biopsies obtained from donors with moderate to severe plaque psoriasis were transplanted on to immuno‐deficient mice. The transplanted mice were treated with anti‐IL‐20 antibodies or recombinant human IL‐20. Results We demonstrate that blocking IL‐20 signalling with anti‐IL‐20 antibodies induces psoriasis resolution and inhibits psoriasis induction. We also demonstrate that continuous IL‐20 infusion, together with injection of additional nonactivated leucocytes, promotes induction of psoriasis in nonlesional skin from patients with psoriasis. Conclusions The results suggest that IL‐20 plays a critical role in the induction and maintenance of psoriasis, and IL‐20 is suggested as a new possible specific target in psoriasis treatment.Keywords
This publication has 42 references indexed in Scilit:
- IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbsProceedings of the National Academy of Sciences, 2007
- Efalizumab in the treatment of chronic plaque psoriasis: experiences from the largest psoriasis treatment centre in DenmarkBritish Journal of Dermatology, 2007
- Interleukin (IL)‐19, IL‐20 and IL‐24 are produced by and act on keratinocytes and are distinct from classical ILsExperimental Dermatology, 2006
- IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2–dependent mechanisms with implications for psoriasis pathogenesisJournal of Experimental Medicine, 2006
- Prominent Production of IL-20 by CD68+/CD11c+ Myeloid-Derived Cells in Psoriasis: Gene Regulation and Cellular EffectsJournal of Investigative Dermatology, 2006
- IL-20, an anti-angiogenic cytokine that inhibits COX-2 expressionBiochemical and Biophysical Research Communications, 2005
- Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasisGenes & Immunity, 2005
- Characterization of the Recombinant Extracellular Domains of Human Interleukin-20 Receptors and Their Complexes with Interleukin-19 and Interleukin-20Biochemistry, 2003
- Psoriasis is Mediated by a Cutaneous Defect Triggered by Activated Immunocytes: Induction of Psoriasis by Cells with Natural Killer ReceptorsJournal of Investigative Dermatology, 2002
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001